K

Kolon Life Science Inc
KOSDAQ:102940

Watchlist Manager
Kolon Life Science Inc
KOSDAQ:102940
Watchlist
Price: 50 800 KRW Market Closed
Market Cap: 630.9B KRW

Operating Margin
Kolon Life Science Inc

-6%
Current
-10%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-6%
=
Operating Profit
-10.9B
/
Revenue
180.6B

Operating Margin Across Competitors

No Stocks Found

Kolon Life Science Inc
Glance View

Market Cap
631.1B KRW
Industry
Pharmaceuticals

KOLON Life Science, Inc. engages in the manufacture and sale of pharmaceuticals and environment materials. The company is headquartered in Seoul, Seoul and currently employs 451 full-time employees. The company went IPO on 2009-04-07. The firm operates its business under two segments. The Chemical Business segment produces and sells raw drug products, which are the raw materials of new drugs and generic drugs, antibacterial agents that suppress bacterial growth, water treatment agents for environmental purification, and functional material products for cosmetics. The Bio Business segment manufactures and sells bio new medicines based on cell gene therapy products.

Intrinsic Value
23 584.16 KRW
Overvaluation 54%
Intrinsic Value
Price
K
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-6%
=
Operating Profit
-10.9B
/
Revenue
180.6B
What is the Operating Margin of Kolon Life Science Inc?

Based on Kolon Life Science Inc's most recent financial statements, the company has Operating Margin of -6%.

Back to Top